SCHEMBL4412693

SCHEMBL4412693

Cc1ccc(NC(=O)c2cc(C#N)cc(N3CCOCC3)c2)cc1-c1cc(C(=O)NCC(C)(C)C)on1

nearest known ligand 0.49

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 19/20 0.49
BRAF P15056 19/20 0.49
CSF1R P07333 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4409551 0.95 RAF1 (0.43) RAF1BRAFCSF1R
SCHEMBL4409531 0.94 RAF1 (0.42) RAF1BRAFCSF1R
SCHEMBL5603943 0.89 RAF1 (0.45) RAF1BRAF
SCHEMBL4565118 0.89 RAF1 (0.56) RAF1BRAFCSF1R
SCHEMBL4552241 0.87 RAF1 (0.63) RAF1BRAFCSF1R
SCHEMBL4541481 0.87 RAB9A (0.47) RAF1BRAFCSF1R
SCHEMBL4408526 0.87 RAF1 (0.57) RAF1BRAF
SCHEMBL4418487 0.86 MAPK14 (0.48) RAF1BRAFCSF1R
SCHEMBL4551383 0.86 BRAF (0.54) RAF1BRAF
SCHEMBL4551893 0.86 RAF1 (0.54) RAF1BRAFCSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2035005-A2 THERAPY USING CYTOKINE INHIBITORS Kemia, INC. (US) 2009-03-18 EP disclosed
WO-2007146712-A2 THERAPY USING CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-12-21 WO disclosed
WO-2007075896-A2 HETEROCYCLIC CYTOKINE INHIBITORS KEMIA, INC. (US) 2007-07-05 WO disclosed